NO20076052L - Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen - Google Patents

Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen

Info

Publication number
NO20076052L
NO20076052L NO20076052A NO20076052A NO20076052L NO 20076052 L NO20076052 L NO 20076052L NO 20076052 A NO20076052 A NO 20076052A NO 20076052 A NO20076052 A NO 20076052A NO 20076052 L NO20076052 L NO 20076052L
Authority
NO
Norway
Prior art keywords
compounds
treatment
oxabispidin
new
cardiac arrhythmias
Prior art date
Application number
NO20076052A
Other languages
English (en)
Inventor
Annika Bjore
Gert Strandlund
Adam Herring
David Cladingboel
Carl-Gustaf Sigfridsson
Christina Olsson
Johan Kajanus
Gareth Ensor
Robert Lundqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/SE2005/000891 external-priority patent/WO2005123748A1/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20076052L publication Critical patent/NO20076052L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Det tilveiebringes forbindelser med formel I, hvor R1, R2, R3, R41 til R46, X, Y og Z har betydningene som er angitt i beskrivelsen, som er anvendelige ved forebygging og behandling av arytmier, spesielt atriale og ventrikulære arytmier.
NO20076052A 2005-06-13 2007-11-26 Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen NO20076052L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/SE2005/000891 WO2005123748A1 (en) 2004-06-15 2005-06-13 Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias
SE0502775 2005-12-15
PCT/SE2006/000688 WO2006135316A1 (en) 2005-06-13 2006-06-12 New oxabispidine compounds for the treatment of cardiac arrhythmias

Publications (1)

Publication Number Publication Date
NO20076052L true NO20076052L (no) 2008-03-11

Family

ID=37532579

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076052A NO20076052L (no) 2005-06-13 2007-11-26 Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen

Country Status (12)

Country Link
US (1) US7928225B2 (no)
EP (1) EP1893619A1 (no)
JP (1) JP2008543750A (no)
KR (1) KR20080021114A (no)
CN (1) CN101243093A (no)
AR (1) AR057064A1 (no)
AU (1) AU2006258293B2 (no)
CA (1) CA2609938A1 (no)
EC (1) ECSP078025A (no)
MX (1) MX2007015800A (no)
NO (1) NO20076052L (no)
WO (1) WO2006135316A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2538254T3 (es) 2006-04-18 2015-06-18 Emisphere Technologies, Inc. Agentes de administración de dialquil éter
TW200940110A (en) * 2008-02-22 2009-10-01 Astrazeneca Ab Pharmaceutical formulation comprising oxabispidines
TW201004963A (en) * 2008-07-03 2010-02-01 Targacept Inc Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
WO2010059119A1 (en) * 2008-11-21 2010-05-27 Astrazeneca Ab A combination of tert -butyl (2-{7- [2- (4-cyano-2- f luorophenoxy) ethyl] -9-oxa-3, 7-diazabicyclo [3.3.1] non-3- yl } ethyl) carbamate and certain antiarrhythmic benzofurans

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3503939A (en) 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
CH488048A (de) 1969-06-12 1970-03-31 Inventa Ag Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung
DE2428792A1 (de) 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
JPS5772977A (en) 1980-10-23 1982-05-07 Dainippon Ink & Chem Inc Fluorine-containing diepoxy compound and its preparation
DE3112055A1 (de) 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
DE3234697A1 (de) 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4533713A (en) 1983-05-06 1985-08-06 Minnesota Mining And Manufacturing Company Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups
PT88381B (pt) 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
FI100151B (fi) 1992-09-04 1997-09-30 Nokia Mobile Phones Ltd Tehonsäästö matkaviestimessä
JPH06284071A (ja) 1993-01-27 1994-10-07 Casio Comput Co Ltd 無線受信機
US5468858A (en) 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
FR2713081B1 (fr) 1993-11-29 1996-01-12 Celsa Lg Filtre sanguin perfectionné à deux séries de pattes en pétales.
US5831099A (en) 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
JP2002541249A (ja) 1999-04-09 2002-12-03 アストラゼネカ・アクチエボラーグ アダマンタン誘導体
SE9903759D0 (sv) 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
AR030756A1 (es) 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0101323D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101324D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101327D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
TWI259836B (en) 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0201662D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Pharmaceutical combination
CN1681495B (zh) * 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401540D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
CA2609938A1 (en) 2006-12-21
MX2007015800A (es) 2008-03-04
AU2006258293A1 (en) 2006-12-21
AR057064A1 (es) 2007-11-14
US20090054422A1 (en) 2009-02-26
EP1893619A1 (en) 2008-03-05
ECSP078025A (es) 2008-01-23
WO2006135316A1 (en) 2006-12-21
JP2008543750A (ja) 2008-12-04
US7928225B2 (en) 2011-04-19
KR20080021114A (ko) 2008-03-06
AU2006258293B2 (en) 2010-06-17
CN101243093A (zh) 2008-08-13

Similar Documents

Publication Publication Date Title
NO20021811L (no) Nye oksabispidinforbindelser som er nyttige i behandlingen av hjertearrytmier
NO20070148L (no) Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
NO20090031L (no) Isoindolinderivater for behandling av arytmi
NO20064456L (no) Thiadiazolidinoner som GSK-3 inhibitorer
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20075186L (no) Substituerte glycinamider som har antitrombotisk og faktor XA-inhiberende effekt.
WO2009046841A3 (de) Piperidin- und piperazinderivate zur behandlung von tumoren
NO20083207L (no) Inhibitorer av IAP
NO20055688L (no) Organiske forbindelser
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20081196L (no) Terapeutisk middel for diabetes
NO20080981L (no) Nitrocatechol-derivater som COMT-inhibitorer
NO20051965D0 (no) Nye piperidinderivater for anvendelse ved behandling av kemokinmedierte sykdomstilstander.
NO20085068L (no) Fenylamino-benzoksazolsubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20070089L (no) DPP-IV inhibitorer
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
NO20064576L (no) Pyrimidin-derivater for behandling av avvikende celle vekst
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20081804L (no) Pyrazolforbindelser egnet til behandling av inflammasjon
NO20061789L (no) Aminopyridinderivater som induserbare NO-syntaseinhibitorer
TW200734342A (en) New compounds for the treatment of cardiac arrhythmias
WO2006133928A3 (en) Use of phenylsemicarbazones for seed treatment
NO20070147L (no) Nye oksabispidinforbindelser og deres anvendelse ved behandling av forstyrrelser i hjerterytmen
NO20076052L (no) Nye oksabispidinforbindelser for behandling av forstyrrelser i hjerterytmen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application